Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 39 of 39 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/01/17
End: 09/01/17
Due: 09/01/18
Phase: N/A
Priority: Normal
Start: 10/01/16
End: 04/30/18
Due: 04/30/19
Phase: N/A
Priority: Normal
Start: 01/24/18
End: 12/01/19
Due: 12/01/20
Median Effective Dose of Remifentanil for the Prevention of Myoclonus Induced by Etomidate Injection
Phase: N/A
Priority: Normal
Start: 03/01/23
End: 07/01/23
Due: 07/01/24
Phase: N/A
Priority: Normal
Start: 09/01/20
End: 11/30/20
Due: 11/30/21
Phase: N/A
Priority: Normal
Start: 05/01/24
End: 07/01/25
Due: 07/01/26
Phase: N/A
Priority: Normal
Start: 06/01/23
End: 06/01/24
Due: 06/01/25
Phase: N/A
Priority: Normal
Start: 01/01/17
End: 08/30/20
Due: 08/30/21
Phase: N/A
Priority: Normal
Start: 11/01/20
End: 06/30/21
Due: 06/30/22
Phase: N/A
Priority: Normal
Start: 09/08/19
End: 03/16/21
Due: 03/16/22
Phase: N/A
Priority: Normal
Start: 01/10/23
End: 12/30/23
Due: 12/30/24
Phase: N/A
Priority: Normal
Start: 06/01/22
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 07/01/23
End: 10/31/23
Due: 10/31/24
Phase: N/A
Priority: Normal
Start: 05/01/19
End: 10/01/20
Due: 10/01/21